AVEO Oncology
AVEO
#7099
Rank
HK$4.05 B
Marketcap
HK$116.77
Share price
0.00%
Change (1 day)
170.86%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : HK$0.30 Billion

According to AVEO Oncology 's latest financial reports the company's total debt is HK$0.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31HK$0.29 B163.82%
2020-12-31HK$0.11 B-8.6%
2019-12-31HK$0.12 B-17.62%
2018-12-31HK$0.14 B3.25%
2017-12-31HK$0.14 B32.94%
2016-12-31HK$0.10 B47.92%
2015-12-31HK$73.4 M-54.17%
2014-12-31HK$0.16 B7.56%
2013-12-31HK$0.14 B-26.21%
2012-12-31HK$0.20 B7.51%
2011-12-31HK$0.18 B3.08%
2010-12-31HK$0.18 B18.96%
2009-12-31HK$0.15 B-5.91%
2008-12-31HK$0.16 B38.4%
2007-12-31HK$0.11 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
HK$51.30 B 16,937.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$21.06 B 6,894.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$0.12 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.33 B 131,857.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.89 B 109,792.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$424.93 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA